Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking. Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R. Sci Rep. 2022 Aug 30;12(1):14754.

30 Aug 2022
0

Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking.

Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R.

Sci Rep. 2022 Aug 30;12(1):14754.

Tags

Share this

Related Posts

Longan (Dimocarpus longan Lour.) inhibits liposaccharide-stimulated nitric oxide production in macrophages by suppressing NF-kB and AP-1 signaling pathways. Kunworarah N, Rankadilok N, Suriyo T, Thiantanawat A, Satayavivad J. J Ethnopharmacol 2016; 179: 156-61.

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)